Updated data for Lilly's Inluriyo™ (imlunestrant) reinforce efficacy results as monotherapy and in combination with Verzenio® (abemaciclib) in ER+, HER2- advanced breast cancer

Eli Lilly and Company (NYSE: LLY) today announced updated results from the Phase 3 EMBER-3 study of Inluriyo (imlunestrant), an oral estrogen receptor antagonist, in patients with estrogen receptor ...

First Atlantic Nickel Acquires Ophiolite-X Project Targeting White and Orange Geologic Hydrogen, Carbon Capture, and Critical Minerals in Western Newfoundland

WINDSOR, Newfoundland and Labrador, Dec. 11, 2025 (GLOBE NEWSWIRE) -- First Atlantic Nickel Corp. (TSXV: FAN) (OTCQB: FANCF) ...
Goldseiten

Grande Portage Reports Advancements of Transportation Infrastructure at the New Amalga Gold Project

Grande Portage Resources Ltd. is pleased to announce an update regarding transportation infrastructure for its New Amalga Gold property in Southeast Alaska. The current development concept for the ...